niacinamide has been researched along with sr141716 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cinar, R; Deschamps, J; Godlewski, G; Ikeda, SR; Iyer, MR; Kunos, G; Lee, YS; Liu, J; Puhl, H; Steinbach, PJ; Szanda, G | 1 |
2 other study(ies) available for niacinamide and sr141716
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists.
Topics: Animals; Brain; Cannabinoid Receptor Antagonists; HEK293 Cells; Humans; Isoleucine; Mice; Models, Molecular; Niacinamide; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Species Specificity; Structure-Activity Relationship; X-Ray Diffraction | 2015 |